title: Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
abstract: Adenosine deaminase (ADA) deficiency causes an autosomal recessive form of severe combined immunodeficiency and also less severe phenotypes, depending to a large degree on genotype. In general, ADA activity in cells of carriers is approximately half-normal. Unexpectedly, healthy first-degree relatives of two unrelated ADA-deficient severe combined immunodeficient patients (mother and brother in family I; mother in family II) had only 1-2% of normal ADA activity in PBMC, lower than has previously been found in PBMC of healthy individuals with so-called "partial ADA deficiency." The level of deoxyadenosine nucleotides in erythrocytes of these paradoxical carriers was slightly elevated, but much lower than levels found in immunodeficient patients with ADA deficiency. ADA activity in EBV-lymphoblastoid cell lines (LCL) and T cell lines established from these carriers was 10-20% of normal. Each of these carriers possessed two mutated ADA alleles. Expression of cloned mutant ADA cDNAs in an ADA-deletion strain of Escherichia coli indicated that the novel mutations G239S and M310T were responsible for the residual ADA activity. ADA activity in EBV-LCL extracts of the paradoxical carriers was much more labile than ADA from normal EBV-LCL. Immunoblotting suggested that this lability was due to denaturation rather than to degradation of the mutant protein. These results further define the threshold level of ADA activity necessary for sustaining immune function.
authors.affiliation: Department of Human Gene Therapy and Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan. tada-ari@med.hokudai.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Ariga
authors.forename: N
authors.initials: N
authors.lastname: Oda
authors.forename: I
authors.initials: I
authors.lastname: Sanstisteban
authors.forename: F X
authors.initials: FX
authors.lastname: Arredondo-Vega
authors.forename: M
authors.initials: M
authors.lastname: Shioda
authors.forename: H
authors.initials: H
authors.lastname: Ueno
authors.forename: K
authors.initials: K
authors.lastname: Terada
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: M S
authors.initials: MS
authors.lastname: Hershfield
authors.forename: Y
authors.initials: Y
authors.lastname: Sakiyama
mesh_terms: D000243:Adenosine Deaminase / Q000096:biosynthesis / Q000097:blood* / Q000172:deficiency* / Q000235:genetics; D000483:Alleles; D002461:Cell Line, Transformed; D003001:Cloning, Molecular; D004252:DNA Mutational Analysis; D003839:Deoxyadenosines / Q000235:genetics / Q000378:metabolism; D004789:Enzyme Activation / Q000235:genetics; D004795:Enzyme Stability / Q000235:genetics; D004926:Escherichia coli / Q000201:enzymology / Q000235:genetics; D005260:Female; D020869:Gene Expression Profiling; D006580:Genetic Carrier Screening; D006358:Hot Temperature; D006801:Humans; D007223:Infant; D008297:Male; D020125:Mutation, Missense; D010375:Pedigree; D016511:Severe Combined Immunodeficiency / Q000097:blood / Q000201:enzymology* / Q000235:genetics* / Q000276:immunology
chemical_list: D003839:Deoxyadenosines; D000243:Adenosine Deaminase; C058118:2'-deoxyadenosine